Targeted therapies in colorectal carcinoma: addressing toxicities associated with EGFR inhibitors.
Biedrzycki
Barbara A
BA
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD, USA.
D000970:Antineoplastic Agents / Q000009:adverse effects*; D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000628:therapy*; D016503:Drug Delivery Systems / Q000009:adverse effects* / Q000379:methods / Q000451:nursing; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000209:etiology; D016903:Drug Monitoring; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005128:Eye Diseases / Q000139:chemically induced; D006801:Humans; D008275:Magnesium Deficiency / Q000139:chemically induced; D009367:Neoplasm Staging; D024802:Nurse's Role; D009859:Oncology Nursing; D018579:Patient Selection; D011788:Quality of Life